[go: up one dir, main page]

AR093574A1 - APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS - Google Patents

APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS

Info

Publication number
AR093574A1
AR093574A1 ARP130104294A ARP130104294A AR093574A1 AR 093574 A1 AR093574 A1 AR 093574A1 AR P130104294 A ARP130104294 A AR P130104294A AR P130104294 A ARP130104294 A AR P130104294A AR 093574 A1 AR093574 A1 AR 093574A1
Authority
AR
Argentina
Prior art keywords
protein
aptameros
myeline
against basic
agents
Prior art date
Application number
ARP130104294A
Other languages
Spanish (es)
Inventor
Guido Rozenblum Tomas
Daniel Vitullo Alfredo
Original Assignee
Consejo Nac De Investig Cientificas Y Tecn (Conicet)
Univ Maimonides
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Nac De Investig Cientificas Y Tecn (Conicet), Univ Maimonides filed Critical Consejo Nac De Investig Cientificas Y Tecn (Conicet)
Priority to ARP130104294A priority Critical patent/AR093574A1/en
Priority to PCT/IB2014/066107 priority patent/WO2015075622A1/en
Publication of AR093574A1 publication Critical patent/AR093574A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente provee aptámeros contra la Proteína Básica de Mielina (MBP), así como su aplicación como agentes neuroprotectores en pacientes con Esclerosis Múltiple y como agentes de detección de MBP.This provides aptamers against Basic Myelin Protein (MBP), as well as its application as neuroprotective agents in patients with Multiple Sclerosis and as MBP detection agents.

ARP130104294A 2013-11-21 2013-11-21 APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS AR093574A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP130104294A AR093574A1 (en) 2013-11-21 2013-11-21 APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS
PCT/IB2014/066107 WO2015075622A1 (en) 2013-11-21 2014-11-17 Aptamers against the myelin basic protein as neuroprotective agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP130104294A AR093574A1 (en) 2013-11-21 2013-11-21 APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS

Publications (1)

Publication Number Publication Date
AR093574A1 true AR093574A1 (en) 2015-06-10

Family

ID=52114031

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104294A AR093574A1 (en) 2013-11-21 2013-11-21 APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS

Country Status (2)

Country Link
AR (1) AR093574A1 (en)
WO (1) WO2015075622A1 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
CA2084987C (en) 1990-06-11 2007-02-13 Larry Gold Nucleic acid ligands
US5861254A (en) 1997-01-31 1999-01-19 Nexstar Pharmaceuticals, Inc. Flow cell SELEX
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
DE552178T1 (en) 1990-10-12 1994-02-03 Max Planck Gesellschaft MODIFIED RIBOZYMS.
US5817635A (en) 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
AU2001296305B2 (en) 2000-09-26 2007-12-06 Duke University RNA aptamers and methods for identifying the same
WO2012149024A2 (en) * 2011-04-28 2012-11-01 Mayo Foundation For Medical Education And Research Dna aptamers for promoting remyelination

Also Published As

Publication number Publication date
WO2015075622A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
IL254594A0 (en) Techniques for authorizing and personalizing social messages
CL2016001586A1 (en) Therapy combined with an anti-ang2 antibody and a CD40 agonist
BR302013006822S1 (en) Configuration applied in medical bandage.
EP3063691A4 (en) DYNAMIC DISINFECTION AND ANONYMITY
BR112015023275A8 (en) Mirna biogenesis in exosomes for diagnosis and therapy.
UY4234Q (en) CONFIGURATION APPLIED IN SHOE
SI2986304T1 (en) Pharmaceutical composition, treatment procedures and its uses
BR302013004731S1 (en) CONFIGURATION APPLIED TO TABLE AND SEAT
CL2015003496A1 (en) Therapeutic anti-wall and conjugate antibodies.
EP3006738A4 (en) Rapid-discharge-valve structural body and diaphragm pump
PH12016500232A1 (en) Causing display of a notification
UY4210Q (en) CHAIR
EP2957579A4 (en) COPOLYMER AND MOLDED BODY
BR112015016577A2 (en) retainer and syringe
PL3042669T3 (en) Anti-cancer agent and anti-cancer effect enhancing agent
EP2967516A4 (en) EXPANSION AND CONTENT DELIVERY SYSTEM
FR3005663B1 (en) VERBAL LYOPHILISATE AND USES THEREOF
HUE052236T2 (en) Drug delivery device assembly and drug delivery device
UY4314Q (en) CONFIGURATION APPLIED IN SHOE
UY4233Q (en) CONFIGURATION APPLIED IN SHOE
UY4248Q (en) CHAIR
BR112015025165A2 (en) vehicle
CL2016000171A1 (en) Metaxalone formulation.
AR093574A1 (en) APTAMEROS AGAINST BASIC MYELINE PROTEIN AS NEUROPROTECTING AGENTS
BR112015016741A2 (en) composition, device and system

Legal Events

Date Code Title Description
FG Grant, registration